Yumi Mitsuya, MD
Assistant Professor
Orthopaedic Surgery
School of Medicine

Education & Training

Show all (3) Hide

• M.D. Albany Medical College
• Residency, Physical Medicine and Rehabilitation Stanford University
• Residency, Pediatrics UCSF Benioff Children's Hospital Oakland

Publications (10)

Top publication keywords:
HIV Reverse TranscriptaseSulfonamidesNucleosidesDrug Resistance, Multiple, ViralSequence Analysis, DNAHIV-1HIV ProteaseHIV InfectionsDrug Resistance, ViralSuppression, GeneticProtease InhibitorsCodonRNA, ViralMutation, MissenseDarunavir

• Prototypical Recombinant Multi-Protease-Inhibitor-Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type 1.
  Antimicrobial agents and chemotherapy 2013 Varghese V, Mitsuya Y, Fessel WJ, Liu TF, Melikian GL, Katzenstein DA, Schiffer CA, Holmes SP, Shafer RW
• Human immunodeficiency virus type 1 isolates with the reverse transcriptase (RT) mutation Q145M retain nucleoside and nonnucleoside RT inhibitor susceptibility.
  Antimicrobial agents and chemotherapy 2009 Varghese V, Mitsuya Y, Shahriar R, Bachmann MH, Fessel WJ, Kagan RM, Shafer RW
• Minority human immunodeficiency virus type 1 variants in antiretroviral-naive persons with reverse transcriptase codon 215 revertant mutations.
  Journal of virology 2008 Mitsuya Y, Varghese V, Wang C, Liu TF, Holmes SP, Jayakumar P, Gharizadeh B, Ronaghi M, Klein D, Fessel WJ, Shafer RW
• Viral population estimation using pyrosequencing.
  PLoS computational biology 2008 Eriksson N, Pachter L, Mitsuya Y, Rhee SY, Wang C, Gharizadeh B, Ronaghi M, Shafer RW, Beerenwinkel N
• Prevalence of darunavir resistance-associated mutations: patterns of occurrence and association with past treatment.
  The Journal of infectious diseases 2007 Mitsuya Y, Liu TF, Rhee SY, Fessel WJ, Shafer RW

Show all (5 more) Hide

• Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance.
  Genome research 2007 Wang C, Mitsuya Y, Gharizadeh B, Ronaghi M, Shafer RW
• N88D facilitates the co-occurrence of D30N and L90M and the development of multidrug resistance in HIV type 1 protease following nelfinavir treatment failure.
  AIDS research and human retroviruses 2006 Mitsuya Y, Winters MA, Fessel WJ, Rhee SY, Hurley L, Horberg M, Schiffer CA, Zolopa AR, Shafer RW
• HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/mL.
  Journal of acquired immune deficiency syndromes (1999) 2006 Mitsuya Y, Winters MA, Fessel WJ, Rhee SY, Slome S, Flamm J, Horberg M, Hurley L, Klein D, Shafer RW
• A nitric oxide synthase inhibitor, N(G)-nitro-l-arginine-methyl-ester, exerts potent antiangiogenic effects on plasmacytoma in a newly established multiple myeloma severe combined immunodeficient mouse model.
  British journal of haematology 2003 Uneda S, Hata H, Matsuno F, Nagasaki A, Harada N, Mitsuya Y, Matsuzaki H, Mitsuya H
• Macrophage inflammatory protein-1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM.
  British journal of haematology 2003 Uneda S, Hata H, Matsuno F, Harada N, Mitsuya Y, Kawano F, Mitsuya H